Emcure Pharmaceuticals to Participate in JM Financial Annual India Conference on November 16, 2026
Company officials to meet analysts and investors in Mumbai without sharing unpublished price sensitive information
Emcure Pharmaceuticals Limited announced its participation in the JM Financial Annual India Conference - India Xchange 2026, scheduled for November 16, 2026, in Mumbai. The company will engage with analysts and investors physically, with no unpublished price sensitive information to be shared during the meeting.
Emcure Pharmaceuticals Limited
General / Other
Emcure Pharmaceuticals Limited has scheduled its participation in the JM Financial Annual India Conference - India Xchange 2026 on November 16, 2026, in Mumbai, offering a platform for engagement with analysts and investors.
The event will be held physically in Mumbai, where Emcure Pharmaceuticals' officials will meet with industry analysts and investors.
The company confirmed that no unpublished price sensitive information will be shared during this meeting, maintaining compliance with regulatory requirements.
The schedule is tentative and subject to change due to exigencies by either the company or investors.
Highlights
- Investor meeting set for November 16, 2026, in Mumbai at the JM Financial Annual India Conference.
- Physical mode of interaction planned with analysts and investors.
- No unpublished price sensitive information will be disclosed during the meeting.
- Schedule may change depending on circumstances involving company or investors.
Key Data Snapshot
What happened
- Emcure Pharmaceuticals announced its planned participation in the JM Financial Annual India Conference scheduled for November 16, 2026.
- The participation involves meetings with analysts and investors.
- The meeting will be held in Mumbai in physical format.
Key details
- No unpublished price sensitive information will be shared at the meeting.
- The schedule is tentative and may change due to exigencies on the company or investor side.
- The event provides an opportunity for direct engagement with financial analysts and institutional investors.
Regulatory and governance context
- The disclosure is made pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Emcure Pharmaceuticals confirms compliance by not sharing any unpublished price sensitive information during the investor interactions.
Highlights
- Investor meeting set for November 16, 2026, in Mumbai at the JM Financial Annual India Conference.
- Physical mode of interaction planned with analysts and investors.
- No unpublished price sensitive information will be disclosed during the meeting.
- Schedule may change depending on circumstances involving company or investors.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Sobhagya Mercantile Ltd. Sets Extraordinary General Meeting for December 11, 2026, via Video Conferencing
Sobhagya Mercantile Limited has issued a public notice convening an Extraordinary General Meeting (EGM) scheduled for December 11, 2026, at 11:30 A.M. IST. The meeting will be conducted through video conferencing and other audio-visual means, with e-voting facilities provided to shareholders.
Read Full StoryAPL Apollo Tubes Denies Promoter Stake Sale Rumors Following Speculative News
APL Apollo Tubes Limited issued a clarification on November 20, 2026, denying any knowledge or communication regarding a proposed sale of promoter family shares amid speculative media reports.
Read Full StoryIndusInd Bank Conducts November 2026 Investor and Analyst Meetings in Chennai with Leading Asset Managers
On November 19, 2026, IndusInd Bank Limited conducted analyst and institutional investor meetings in Chennai, involving prominent asset management companies such as Franklin Templeton, Bandhan AMC, Axis AMC, and Motilal Oswal AMC. The bank clarified no unpublished price sensitive information was shared during these discussions.
Read Full Story